Compare · PM vs XXII
PM vs XXII
Side-by-side comparison of Philip Morris International Inc (PM) and 22nd Century Group Inc. (XXII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PM and XXII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $320.42B, about 965.1x XXII ($332.0M).
- Both names hit the wire about 3 times in the past 4 weeks.
- PM has more recent analyst coverage (25 ratings vs 4 for XXII).
- Company
- Philip Morris International Inc
- 22nd Century Group Inc.
- Price
- -
- -
- Market cap
- $320.42B
- $332.0M
- 1M return
- -
- -80.43%
- 1Y return
- -
- -99.92%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- AMEX
- IPO
- News (4w)
- 3
- 3
- Recent ratings
- 25
- 4
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
22nd Century Group Inc.
22nd Century Group, Inc., a biotechnology company, develops plant-based solutions for the life science, consumer product, and pharmaceutical markets. It develops very low nicotine content tobacco and cigarette products under the Moonlight and Moonlight Menthol names; and SPECTRUM research cigarettes for use in independent clinical studies. 22nd Century Group, Inc. has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Latest PM
- Philip Morris International Announces EU Economic Footprint Study 2021-2025: Transformation Made in Europe
- Philip Morris International to Host Webcast of 2026 Third-Quarter and First Nine-Months Results
- Philip Morris International Publishes Inaugural Taskforce on Nature-related Financial Disclosures Report
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Philip Morris International Increases Dividend by 8.8% to Annualized Rate of $6.40 per Share
- New WSJ Intelligence Survey Highlights the Human Skills Companies Must Protect as AI Enters the Workplace
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Philip Morris International Participates in 2026 Barclays Global Consumer Conference; Raises 2026 Full-Year Diluted EPS Forecast for Currency Only
- PMI U.S. Launches ZYN "When It Clicks," a New Brand Platform Built Around the Moment Everything Falls Into Place
Latest XXII
- 22nd Century Same Store Unit Sales for Pinnacle VLN® and Pinnacle Pure Surge 161%
- 22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
- 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule
- 22nd Century Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- 22nd Century CEO & Chairman Larry Firestone: Improved Gross Margin, ~5,000 Retail Outlets and >$50B Market Opportunity Highlight Mid-Year Stockholder Letter
- 22nd Century Group to Participate in the HC Wainwright Conference on September 15, 2026
- SEC Form S-8 filed by 22nd Century Group Inc.
- SEC Form 10-Q filed by 22nd Century Group Inc.
- 22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- 22nd Century Group Reports Second Quarter 2026 Financial Results